Avesthagen launches seven new botanical bioactives under the Avesta brand. It leads new wave in bionutrition.  It uses two of its patented technologies to develop the bioActives.

Avesthagen Limited announced the launch of seven new botanical bioactives under the Avesta brand aimed to promote wellness through prevention of specific degenerative conditions like diabetes, bone loss and cardiovascular diseases. The bioActives will be available as dietary supplements appealing to the Youthful as well as in cereal bars and cracker categories. Avesthagen uses two of its patented technologies to develop the bioActives; Adept a comprehensive database that brings together traditional medicine with modern systems biology and MetaGrid, a unique algorithm that enables comprehensive constituent profiling. The metabolic fingerprints generated not only help chararacterize the bioActives but also help in quality control and assurance. The MetaGrid also helps maintain batch-to-batch reproducibility of the bioactive, which is an issue in conventional systems. Avesthagen uses cell-based assays and GLP-compliant preclinical studies to ensure safety and efficacy of the bioActives. Organoleptic optimization is done to improve the taste and other properties. The bioActives are manufactured in an ISO 9001:2000, ISO22000:2005 facility.

Related Items:

---

Be first to comment this article

Only registered users can write comments.
Please login or register.